Thermo Fisher Scientific IncTMO:NYQ

132.00
2.34 / 1.74%
1.80m
8.30%
0.9066
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 01 2015 21:03 BST.

Summary

On Wednesday, Thermo Fisher Scientific Inc (TMO:NYQ) closed at 132.00, 5.06% below its 52-week high of 139.03, set on Mar 24, 2015.

52-week range
Today
107.33
Oct 15 2014
139.03
Mar 24 2015
Markit short selling activity
Low
Medium
High
Open134.67
Day high134.72
Day low131.29
Bid130.00
Offer138.77
Previous close134.34
Average volume2.01m
Shares outstanding396.78m
Free float396.24m
P/E (TTM)28.50
Market cap53.30bn USD
EPS (TTM)4.71 USD
Annual div (IAD)0.60 USD
Annual div yield (IAD)0.45%
Div ex-dateMar 12 2015
Div pay-dateApr 15 2015
Data delayed at least 15 minutes, as of Apr 01 2015 21:03 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Thermo Fisher Scientific Inc-1.28%+1.54%+10.40%+8.30%+154.97%
S&P 500 INDEX+0.33%-1.74%+6.25%+9.67%+75.53%
USA/HEALTH CARE-1.18%-0.27%+12.62%+18.70%+55.87%
USA/LIFE SCI TOOLS&SVC-0.21%-0.51%+11.34%+10.64%+56.70%
Data delayed at least 15 minutes, as of Apr 01 2015 21:03 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.